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Abstract
Background: Modified nucleotides are increasingly being utilized in the de novo selection of aptamers for enhancing their
drug-like character and abolishing the need for time consuming trial-and-error based post-selection modifications. Locked
nucleic acid (LNA) is one of the most prominent and successful nucleic acid analogues because of its remarkable properties,
and widely explored as building blocks in therapeutic oligonucleotides. Evolution of LNA-modified RNA aptamers requires
an efficient reverse transcription method for PCR enrichment of the selected RNA aptamer candidates. Establishing this key
step is a pre-requisite for performing LNA-modified RNA aptamer selection.
Methodology: In this study three different reverse transcriptases were investigated towards the enzymatic recognition of
LNA nucleotides. Both incorporation as well as reading capabilities of the LNA nucleotides was investigated to fully
understand the limitations of the enzymatic recognition.
Conclusions: We found that SuperScriptH III Reverse Transcriptase is an efficient enzyme for the recognition of LNA
nucleotides, making it a prime candidate to be used in de novo selection of LNA containing RNA aptamers
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Introduction
Nucleic acid-based therapeutic approaches have gained signif-
icant interests in recent years towards the development of drugs
against many diseases. Nucleic acid aptamers [1–5] are an
emerging class of therapeutic molecules, and a chemically-
modified RNA aptamer MacugenH (Pegaptanib sodium), an
inhibitor of vascular endothelial growth factor (VEGF) has been
approved for the treatment of age related macular degeneration
(AMD) [6,7]. To improve the pharmacokinetic properties of
aptamers e.g., nuclease resistance, chemically-modified nucleotides
have to be used. Aptamers are normally generated by an in vitro
evolution process referred to as SELEX (Systematic Evolution of
Ligands by EXponential enrichment) [8–10]. Application of
modified nucleotides in SELEX processes is rather limited because
of their poor substrate properties to various polymerases.
Locked Nucleic Acid (LNA) is one of the most prominent and
successful nucleic acid analogues because of its remarkable
properties, and it is widely explored as building blocks in
therapeutic oligonucleotides [11–14]. LNA nucleotides are
generally considered to be RNA mimicking molecules in which
the ribose sugar moiety is locked by an oxymethylene linkage
connecting the C29 and C49 carbon atoms, imposing conforma-
tional restriction to adopt C39-endo/N -type furanose conforma-
tion (Figure 1) [15–17]. We have previously reported the
enzymatic recognition capabilities of LNA nucleotides by DNA
polymerases towards their applicability in the evolution of DNA
aptamers [18–22]. Evolution of LNA-modified RNA aptamers
requires an efficient reverse transcription method for PCR
enrichment of the selected RNA aptamer candidates. Establishing
this key step is a pre-requisite for performing LNA-modified RNA
aptamer selection. Herein, for the first time, we report an efficient
reverse transcription using LNA nucleotides.
Results and Discussion
First, we investigated LNA-TTP (LNA-T-59-triphosphate) as a
substrate of three different reverse transcriptases; SuperScriptH III,
M-MuLV (Moloney Murine Leukemia Virus) and AMV (Avian
Myo-blastosis Virus). The designed RNA template T1 (43 nt,
Figure 2A) has three sites of incorporations for LNA-T
nucleotides. In all experiments, we included positive and negative
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control reactions, in parallel to the one involving LNA-TTP in
place of dTTP. The positive control reaction contained all four
natural dNTPs, resulting in full-length cDNA products. The
negative control reaction mixture lacked the nucleoside triphos-
phate similar to the LNA nucleotide to be tested for incorporation,
and thus the extension was expected to stop at the nucleotide prior
to the first site of LNA incorporation. The resulting cDNA
products were resolved by denaturing polyacrylamide gel
electrophoresis for which the primer DNA P1 (19 nt, Figure 2A)
was 59-FAM-labelled.
The experiments demonstrated that SuperScriptH III Reverse
Transcriptase efficiently incorporated LNA-T nucleotides, encod-
ed by RNA nucleotides of the template strand, and are capable of
producing full-length cDNA products in good yield (Figure 2B,
lane 4 & C). To check the fidelity and accuracy of the reaction
products, we performed polymerase chain reaction (PCR) using
the cDNA product as the template followed by cloning and
sequencing. We have previously reported the PCR involving
LNA-nucleotides [20]. The sequencing chromatogram clearly
matched with the expected PCR product sequences confirming
the accuracy of the reverse transcription by SuperScriptH III
(Figure S1, supporting information). The yield of full-length cDNA
containing LNA nucleotides was greater at 45 minutes of
incubation (Figure 2C). M-MuLV Reverse Transcriptase was also
able to produce the full-length cDNA, however, it was not as
efficient as SuperScriptH III Reverse Transcriptase (Figure S2B
lane 4, supporting information). AMV Reverse Transcriptase
afforded the full-length cDNA product in only very low yield
(Figure S2C lane 4, supporting information).
Next, we performed an experiment using both LNA-TTP and
LNA-ATP in one reaction by replacing dTTP and dATP. The
designed RNA template sequence T1 directs incorporation of first
three LNA-T nucleotides followed by three LNA-A nucleotides in
the resulting cDNA product. The results show that SuperScriptH
III Reverse Transcriptase efficiently incorporated both LNA-T
and LNA-A nucleotides and furnished the full-length cDNA
product in excellent yield (Figure 3B, lane 4). In this experiment,
Figure 1. Structural representations of LNA monomers.
doi:10.1371/journal.pone.0035990.g001
Figure 2. Enzymatic incorporation of LNA-T nucleotides by SuperScriptH III Reverse Transcriptase. (A) Primer and template sequences.
(B) Gel electrophoresis of incorporation LNA-T, lane 1: Primer, 19 nt; lane 2: Positive control using all four natural dNTPs; lane 3: Negative control
reaction with only three natural nucleotides (dCTP, dATP, dGTP); lane 4: Incorporation of LNA-T (dCTP, dATP, dGTP, LNA-TTP in the mixture). (C) Gel
electrophoresis of incorporation LNA-T at 5–45 minute incubation time points, lane P1: Primer. LNA nucleotides are underlined and the incorporation
sites in the template RNA are italicized.
doi:10.1371/journal.pone.0035990.g002
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both AMV and M-MuLV Reverse Transcriptases failed to afford
the expected full-length cDNA product.
The first enzymatic step involved in RNA aptamer selection by
SELEX is to convert the selected RNA aptamer sequences to a
complementary DNA for PCR amplification. Encouraged by the
initial results, we then performed reverse transcription experiments
using an LNA-modified RNA template T2. The designed RNA
template has four LNA nucleotides with two LNA-A nucleotides
first followed by two LNA-T nucleotides opposite to which the
desired DNA nucleotides have to be incorporated. We have also
conducted one reaction to check the incorporation of LNA-T
nucleotides opposite to LNA-A nucleotides of the template
sequence by replacing dTTP with LNA-TTP in the dNTP
mixture. These experiments revealed that SuperScriptH III
Reverse Transcriptase efficiently transcribed the LNA nucleotides
of the template RNA strand by incorporating DNA nucleotides
and afforded the cDNA product in very good yield (Figure 3C,
lane 2). PCR amplification followed by cloning and subsequent
sequencing analysis was performed to verify the cDNA product.
The resulting sequence chromatogram clearly matched with the
expected PCR product sequences confirming the accuracy of the
reverse transcription using LNA-modified RNA template
(Figure 4C, lane 2 & D). Furthermore, SuperScriptH III Reverse
Transcriptase was able to incorporate LNA-T nucleotides opposite
to LNA-A nucleotides of the template strand and furnished an
LNA-containing full-length cDNA product in reasonably good
yield (Figure 3C, lane 4). AMV and M-MuLV Reverse
Transcriptases were less efficient to afford the full-length cDNA
products compared to the Super Script III Reverse Transcriptase.
In summary, we have demonstrated that SuperScriptH III
Reverse Transcriptase is an efficient enzyme to recognize LNA
nucleotides and to synthesize a complementary DNA copy from
an LNA-modified RNA template. These findings are vital and
pave the way towards applying LNA nucleotides in RNA aptamer
selection by in vitro evolution processes.
Materials and Methods
Materials
DNA sequences were purchased from Integrated DNA
Technologies (Coralville, Iowa). SuperScriptH III Reverse Tran-
scriptase, RNase OUTTM (Ribonuclease inhibitor) and RNase H
were purchased from Invitrogen Australia (Mulgrave, Victoria).
M-MuLV and AMV Reverse Transcriptases were purchased from
New England biolabs (supplied by Genesearch Australia). Phusion
DNA polymerase was purchased from Finnzymes (supplied by
Genesearch Australia).
Reverse transcription
The 59-end labelled primer DNA was annealed with the
templates by mixing primer and template in a molar ratio of 1:2
and heating to 80uC for 3 min followed by slow cooling to 37uC.
For SuperScriptH III Reverse Transcriptase
The reaction mixtures were prepared in a total volume of 20 mL
by adding 4 mL of 56 First Strand buffer, 4 mL of MgCl2
(25 mM), 1.5 mL of dithiothreitol (DTT, 100 mM), 1.5 mL of
dNTPs/LNA-NTPs (2.5 mM of dNTP and 5 mM for LNA-NTP)
mixture, 1.5 mL of a solution containing 59-FAM-labelled primer-
template complex (5:10 pmol ratio), 5 mL of two times distilled
water, 1 mL RNase OUTTM (40 U/mL) and 1 mL of SuperScriptH
III Reverse Transcriptase (250 U/mL). The reaction mixture was
gently vortexed and incubated for 45 min at 50uC. Positive and
negative control reactions were stopped after 3 minutes of
incubation at 50uC as prolonged incubation resulted in product
degradation. Then, the reaction mixtures were heated at 80uC for
5 minutes to inactivate the enzyme. To the resulting mixture, 1 mL
of RANase H (5 U/mL) was added and incubated for 1 h at 37uC.
The reactions were then quenched by the addition of half volume
of loading buffer. Analysis of the products was by performing 13%
7 M urea denaturing polyacrylamide gel electrophoresis in the
presence of TBE buffer (100 mM Tris, 90 mM boric acid, 1 mM
EDTA).
Figure 3. Enzymatic incorporation of LNA-T, LNA-A, dT/LNA-T and dA nucleotides using RNA and LNA/RNA templates. (A) Primer and
template sequences. (B) Gel electrophoresis of LNA-T and LNA-A incorporation on a natural RNA template T1, lane 1: Primer, 19 nt; lane 2: Positive
control using all four natural dNTPs; lane 3: Negative control reaction with only two natural nucleotides (dCTP, dGTP); lane 4: Incorporation of LNA-T
and LNA-A (dCTP, dGTP, LNA-ATP, LNA-TTP in the mixture). (C) Gel electrophoresis of dT/LNA-T and dA nucleotide incorporation using a LNA-A and
LNA-T-modified RNA template T2, lane 1: Primer, 19 nt; lane 2: Positive control using all four natural dNTPs; lane 3: Negative control reaction with only
three natural nucleotides (dCTP, dATP, dGTP); lane 4: Incorporation of LNA-T (dCTP, dATP, dGTP, LNA-TTP in the mixture). LNA nucleotides are
underlined and the incorporation sites in the template RNA are italicized.
doi:10.1371/journal.pone.0035990.g003
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For M-MulV and AMV Reverse Transcriptase
In this case, the reaction mixtures were prepared in a total
volume of 20 mL by adding 2 mL of 106 RT buffer, 4 mL of
dNTPs/LNA-NTPs mixture (prepared the same way as men-
tioned above), 2 mL of a solution containing 59-FAM-labelled
primer-template complex (5:10 pmol ratio), 10 mL of two times
distilled water, 1 mL RNase OUTTM (40 U/mL) and 1 mL of M-
MuLV (200 U/mL) or AMV (10 U/mL) Reverse Transcriptase.
The reaction mixtures were gently vortexed and incubated for 1 h
at 42uC. Positive and negative control reaction was stopped after
3 minutes of incubation at 42uC. Then the reaction mixtures were
heated at 90uC for 10 min to inactivate the enzyme. To the
resulting mixture, 1 mL of RNase H (5 U/mL) was added and
incubated for 1 h at 37uC. The reactions were then quenched by
the addition of half volume of loading buffer and analysed as
discussed above.
General procedure for polymerase chain reactions
The PCR reaction mixture was prepared in a total volume of
50 mL by adding 10 mL 56 Phusion HF buffer (included in the
Phusion DNA polymerase kit), 4 mL of dNTPs (400 mM), 28 mL of
two times distilled water, 1.5 mL of forward primer (50 mM),
1.5 mL of reverse primer (50 mM), 5 mL of template (0,7 mM)
stemming from the reverse transcription and 0,5 mL of Phusion
DNA polymerase (250 U/mL). The reaction mixtures were gently
vortexed and then amplified using a thermal cycler (S1000TM
Thermal cycler, Bio-Rad). A 25-cycle PCR consisted of denatur-
ation at 98uC for 10 second, annealing at 55uC for 15 seconds and
extension at 72uC for 25 seconds. After the polymerase reactions,
gel-loading buffer (included in Ultra Low DNA size marker kit
from Fermentas, supplied by VWR Australia) was added (1.5 mL)
and the products were analysed by 4% agarose gel electrophoresis
followed by UV-photography.
Figure 4. PCR amplification using the cDNA template generated by reverse transcription by SuperScriptH III Reverse Transcriptase.
(A) Primer and template sequences; (B) Agarose gel electrophoresis image of PCR using the cDNA template containing LNA-T generated by
SuperScriptH III Reverse Transcriptase, lane 1: DNA size markers in base-pairs, lane 2: PCR using the cDNA with natural DNA nucleotides, lane 3: PCR
using cDNA template with LNA-T (43 nt), lane 4: PCR without using a template (negative control); (C) Agarose gel electrophoresis image of PCR using
the cDNA template with natural DNA nucleotides and LNA-T nucleotides generated from an LNA-modified RNA template T2 by SuperScriptH III
Reverse Transcriptase, lane 1: DNA size markers in base-pairs, lane 2: PCR using the cDNA with natural DNA nucleotides, lane 3: PCR using cDNA
template with LNA-T, lane 4: PCR without using a template (negative control); (D) PCR product analysis by cloning and sequencing, PCR product
obtained from Figure 4C (lane 2) aligned with the sequencing chromatogram. PCR product containing DNA-T and DNA-A at the expected positions of
the LNA nucleotides of the initial RNA template is matched with a double headed arrow as identified in the sequencing chromatogram.
doi:10.1371/journal.pone.0035990.g004
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Cloning and Sequencing
Purified PCR products (50 ng) were cloned into pCR-Blunt
(Invitrogen) according to the manufacturer’s instructions. Plasmid
DNA was extracted using QIAprep (Qiagen) and sequenced by
the Australian Genome Research Facility (AGRF, Brisbane,
Australia) to validate sequence changes.
Supporting Information
Figure S1 Sequence analysis of PCR product obtained from a
cDNA template containing LNA-T by cloning and sequencing.
Position of LNA-T in the expected PCR product is matched with a
double headed arrow as identified in the sequencing chromato-
gram.
(TIF)
Figure S2 Enzymatic incorporation of LNA-T nucleotides. A.
Primer and template sequences. B. Gel electrophoresis of
incorporation LNA-T by M-MuLV Reverse Transcriptase, lane
1: Primer, 19n; lane 2: Positive control using all four natural
dNTPs; lane 3: Negative control reaction with only three natural
nucleotides (dCTP, dATP, dGTP); lane 4: Incorporation of LNA-
T (dCTP, dATP, dGTP, LNA-TTP in the mixture). B. Gel
electrophoresis of incorporation LNA-T by AMV Reverse
Transcriptase, lane 1: Primer, 19 nt; lane 2: Positive control using
all four natural dNTPs; lane 3: Negative control reaction with only
three natural nucleotides (dCTP, dATP, dGTP); lane 4:
Incorporation of LNA-T (dCTP, dATP, dGTP, LNA-TTP in
the mixture).
(TIF)
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